Kim DW - Search Results

1

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia.

Hochhaus A, Baccarani M, Silver RT, Schiffer C, Apperley JF, Cervantes F, Clark RE, Cortes JE, Deininger MW, Guilhot F, Hjorth-Hansen H, Hughes TP, Janssen JJWM, Kantarjian HM, Kim DW, Larson RA, Lipton JH, Mahon FX, Mayer J, Nicolini F, Niederwieser D, Pane F, Radich JP, Rea D, Richter J, Rosti G, Rousselot P, Saglio G, Saußele S, Soverini S, Steegmann JL, Turkina A, Zaritskey A, Hehlmann R. Hochhaus A, et al. Among authors: kim dw. Leukemia. 2020 Apr;34(4):966-984. doi: 10.1038/s41375-020-0776-2. Epub 2020 Mar 3. Leukemia. 2020. PMID: 32127639 Free PMC article. Review.

2

Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome--positive acute lymphoblastic leukemia.

Ottmann OG, Larson RA, Kantarjian HM, le Coutre PD, Baccarani M, Hochhaus A, Kim DW, Fan X, Novick S, Giles FJ. Ottmann OG, et al. Among authors: kim dw. Leukemia. 2013 Jun;27(6):1411-3. doi: 10.1038/leu.2012.324. Epub 2012 Nov 9. Leukemia. 2013. PMID: 23138184 Clinical Trial. No abstract available.

3

A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias.

Cortes JE, Kim DW, Pinilla-Ibarz J, le Coutre P, Paquette R, Chuah C, Nicolini FE, Apperley JF, Khoury HJ, Talpaz M, DiPersio J, DeAngelo DJ, Abruzzese E, Rea D, Baccarani M, Müller MC, Gambacorti-Passerini C, Wong S, Lustgarten S, Rivera VM, Clackson T, Turner CD, Haluska FG, Guilhot F, Deininger MW, Hochhaus A, Hughes T, Goldman JM, Shah NP, Kantarjian H; PACE Investigators. Cortes JE, et al. Among authors: kim dw. N Engl J Med. 2013 Nov 7;369(19):1783-96. doi: 10.1056/NEJMoa1306494. Epub 2013 Nov 1. N Engl J Med. 2013. PMID: 24180494 Free PMC article. Clinical Trial.

4

Rethinking primary particulate matter: Integrating filterable and condensable particulate matter in measurement and analysis.

Le YT, Kim DW, Kang C, Bae GN, Park PM, Jung YW, Jang KW, Kang DI, Youn JS, Jeon KJ. Le YT, et al. Among authors: kim dw. Sci Total Environ. 2025 Jan 9;961:178396. doi: 10.1016/j.scitotenv.2025.178396. Online ahead of print. Sci Total Environ. 2025. PMID: 39793131

5

The Synergistic Effect of PARP Inhibitors and Irinotecan in Small Cell Lung Cancer Cells.

Oh S, Kim S, Keam B, Youk J, Kim TM, Kim DW, Kim M. Oh S, et al. Among authors: kim dw. Cancer Res Treat. 2025 Jan 7. doi: 10.4143/crt.2024.728. Online ahead of print. Cancer Res Treat. 2025. PMID: 39788642 Free article.

6

Wintering loons in South Korea face an ongoing threat from polycyclic aromatic hydrocarbons: Shifting sources and potential DNA damage¹.

Hur S, Kim DW, Park JG, Lee HR, Kim YJ, Lee BG, Nam DH. Hur S, et al. Among authors: kim dw. Environ Pollut. 2025 Jan 7:125659. doi: 10.1016/j.envpol.2025.125659. Online ahead of print. Environ Pollut. 2025. PMID: 39788179

7

Long-term efficacy and safety of perampanel monotherapy in patients with newly diagnosed or currently untreated recurrent focal-onset seizures: Results from the open-label extension phase of FREEDOM (Study 342).

Yamamoto T, Lim SC, Ninomiya H, Kubota Y, Shin WC, Kim DW, Shin DJ, Iida K, Ochiai T, Matsunaga R, Hiramatsu H, Kim JH. Yamamoto T, et al. Among authors: kim dw. Epilepsy Res. 2024 Dec 20;210:107494. doi: 10.1016/j.eplepsyres.2024.107494. Online ahead of print. Epilepsy Res. 2024. PMID: 39788068

8

Preliminary experience and learning curve of endoscopic nipple-areolar-complex sparing total mastectomy: A single-center retrospective study.

Yu DY, Lee TY, Kim DW, Chang YW, Son GS, Lee HY. Yu DY, et al. Among authors: kim dw. PLoS One. 2025 Jan 9;20(1):e0311764. doi: 10.1371/journal.pone.0311764. eCollection 2025. PLoS One. 2025. PMID: 39787177 Free PMC article.

9

Novel primers drive accurate SYBR Green PCR detection of Listeria monocytogenes and Listeria innocua in cultures and mushrooms.

Kim BE, Jothi R, Kim DW, Park DS. Kim BE, et al. Among authors: kim dw. Sci Rep. 2025 Jan 8;15(1):1357. doi: 10.1038/s41598-024-81508-6. Sci Rep. 2025. PMID: 39779768 Free PMC article.

10

Genomic profiling of intimal sarcoma reveals molecular subtypes with distinct tumor microenvironments and therapeutic implications.

Park C, Kim R, Bae JM, Lee T, Song S, Kwak Y, Lee KB, Youk J, Keam B, Kim TM, Kim DW, Kim JI, Choi J, Kim M. Park C, et al. Among authors: kim dw. ESMO Open. 2025 Jan 6;10(1):104097. doi: 10.1016/j.esmoop.2024.104097. Online ahead of print. ESMO Open. 2025. PMID: 39778225 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,351 results

Search Page

Filters